Bill Sutherland

Q: What is Bill Sutherland's success rate?

Bill Sutherland currently has a success rate of 83.60522982970431.

Q: What is the average return of Bill Sutherland's calls?

Their stock ratings have generated an average return of 21.84558817292805.

Benchmark | Healthcare

Bill Sutherland is an analyst from Benchmark specializing in the Healthcare sector. Ranked #1533 out of 4773 analysts, they have issued 20 stock ratings with a success rate of 83.61% and an average return of 21.85%.

Bill Sutherland has a well-established track record, with 20 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 83.61% and an average return of 21.85%, underscoring their expertise and ability to identify winning opportunities for investors.

#1533

Out of 4773

Total Ratings

+83.61%

Success Rate

+21.85%

Average Return

Recent Ratings Analysis

PRE

Buy

Jul 15, 2026

Target

$40.00

Current

$23.47

Performance

19.87%

Bill Sutherland rated PRE as Buy on Jul 15, 2026, setting a price target of 40. The call has proven timely, with shares rising 19.87% toward the price target of 40.

CXW

Buy

Jul 07, 2026

Target

$41.00

Current

$34.93

Performance

19.22%

On Jul 07, 2026, CXW was given a Buy rating by Bill Sutherland, with a target price of 41. The stock rallied 19.22% after the rating, narrowing the gap to the target of 41 and validating the bullish stance.

AGL

Buy

May 21, 2026

Target

$95.00

Current

$89.77

Performance

11.42%

AGL received a Buy rating from Bill Sutherland on May 21, 2026, aiming for 95. Momentum has favored the Buy call, with shares climbing from 89.77 to 89.77, rewarding those who trusted the recommendation.

BEAT

Buy

May 15, 2026

Target

$5.00

Current

$0.41

Performance

-57.89%

On May 15, 2026, Bill Sutherland published a Speculative Buy outlook on BEAT, with a target of 5. Market action contradicted the Buy thesis, as shares slipped to 0.4064.

HCSG

Buy

Apr 23, 2026

Target

$30.00

Current

$21.98

Performance

1.95%

Bill Sutherland on Apr 23, 2026 assigned HCSG a Buy rating, with a price target of 30. The recommendation remains pending validation as shares consolidate around 21.98.

RCMT

Buy

Apr 08, 2026

Target

$36.00

Current

$40.11

Performance

43.92%

On Apr 08, 2026, Bill Sutherland reaffirmed RCMT with a Buy rating, targeting 36. The recommendation was supported by strong follow-through as the stock rose from 40.11 to 40.11.

CCRN

Buy

Mar 05, 2026

Target

$14.00

Current

$13.25

Performance

—

CCRN was rated Buy by Bill Sutherland on Mar 05, 2026, with a price objective of 14. The stock is in a wait-and-see zone, leaving the Buy case open-ended.

SEM

Hold

Mar 04, 2026

Target

—

Current

$16.51

Performance

—

On Mar 04, 2026, Bill Sutherland initiated coverage on SEM with a Hold rating and target of null. The stock’s lack of movement around 16.51 aligned with a cautious approach.

OMCL

Buy

Feb 02, 2026

Target

$60.00

Current

$32.79

Performance

-32.67%

Bill Sutherland issued a Buy recommendation for OMCL on Feb 02, 2026, price target set at 60. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

HURN

Buy

Dec 24, 2025

Target

$215.00

Current

$149.93

Performance

-16.73%

On Dec 24, 2025, HURN was evaluated by Bill Sutherland, who gave a Buy rating and target of 215. Investors saw limited payoff as shares fell short of the 215 target.

SGRY

Buy

Nov 11, 2025

Target

$30.00

Current

$14.38

Performance

-8.64%

Bill Sutherland rated SGRY as Buy on Nov 11, 2025, setting a price target of 30. The stock has underperformed, dropping 8.64% despite the bullish target of 30.

CCLD

Buy

Nov 15, 2024

Target

$4.50

Current

$2.05

Performance

-17.00%

On Nov 15, 2024, CCLD was given a Buy rating by Bill Sutherland, with a target price of 4.5. Despite the Buy call, shares fell from 2.05 to 2.05, challenging the optimistic stance.

AMN

Hold

Oct 02, 2024

Target

—

Current

$33.34

Performance

-16.15%

AMN received a Hold rating from Bill Sutherland on Oct 02, 2024, aiming for null. The Hold stance proved prudent, with the market softening by 16.15%.

PINC

Hold

Aug 26, 2024

Target

—

Current

$49.58

Performance

147.65%

On Aug 26, 2024, Bill Sutherland published a Hold outlook on PINC, with a target of null. The Hold call missed some of the bullish momentum as shares advanced toward null.

QIPT

Buy

Aug 21, 2024

Target

$7.00

Current

$3.65

Performance

34.69%

Bill Sutherland on Aug 21, 2024 assigned QIPT a Buy rating, with a price target of 7. The Buy call aligned well with market performance, producing a gain of 34.69%.

NUTX

Buy

Aug 21, 2024

Target

$45.00

Current

$200.24

Performance

876.78%

On Aug 21, 2024, Bill Sutherland reaffirmed NUTX with a Buy rating, targeting 45. The recommendation was supported by strong follow-through as the stock rose from 200.24 to 200.24.

Frequency Asked Questions

Who is Bill Sutherland?

Bill Sutherland is an analyst from Benchmark specializing in the Healthcare sector.

What is Bill Sutherland's success rate?

Bill Sutherland currently has a success rate of +83.61%.

How many ratings has Bill Sutherland issued?

Bill Sutherland has issued 20 stock ratings so far.

What is the average return of Bill Sutherland's calls?

Their stock ratings have generated an average return of +21.85%.

What is Bill Sutherland's ranking?

Bill Sutherland is ranked #1533 out of 4773 analysts.

What types of ratings does Bill Sutherland give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Bill Sutherland?

You can follow Bill Sutherland by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Bill Sutherland?

Their latest rating was a Buy on PRE issued on 2026-07-15.